Pages that link to "Q26851274"

The following pages link to Effects of anti-tumor necrosis factor α agents on bone (Q26851274):

Displaying 22 items.

• Risk factors for osteoporosis in inflammatory bowel disease patients (Q26776142) (← links)
• The alliance of mesenchymal stem cells, bone, and diabetes (Q27012497) (← links)
• Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials (Q27025358) (← links)
• Cytokine-mediated bone destruction in rheumatoid arthritis (Q34252489) (← links)
• Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner (Q35795868) (← links)
• Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL (Q36124211) (← links)
• Drp1-dependent mitochondrial fission mediates osteogenic dysfunction in inflammation through elevated production of reactive oxygen species (Q36339998) (← links)
• Causes, mechanisms and management of paediatric osteoporosis (Q38099517) (← links)
• The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study (Q38831693) (← links)
• Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice (Q39085876) (← links)
• Decreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study (Q44303831) (← links)
• Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNFα therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trab (Q45832844) (← links)
• Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study (Q48044952) (← links)
• Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw. (Q48220380) (← links)
• In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice (Q49387533) (← links)
• Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine (Q51816827) (← links)
• Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies. (Q53060269) (← links)
• Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables (Q59511343) (← links)
• Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls (Q90133923) (← links)
• A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol (Q91962788) (← links)
• Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats (Q92136327) (← links)
• Mycobacterium tuberculosis infection increases the number of osteoclasts and inhibits osteoclast apoptosis by regulating TNF-α-mediated osteoclast autophagy (Q98386302) (← links)